Overview
GHB acts on several nerve pathways in the brain and has been used in drug-facilitated sexual assault and as a party drug. Due to safety concerns, it is a Schedule I controlled substance, making it illegal.
A prescription form of GHB called sodium oxybate (Xyrem) is used for treating excessive daytime sleepiness (narcolepsy). People also use GHB for alcohol use disorder, opioid withdrawal, depression, and other conditions, but there is no good scientific evidence to support these uses.
Uses & Effectiveness ?
Effective for
- Excessive daytime sleepiness (narcolepsy). Taking a specific prescription form of GHB by mouth helps people with narcolepsy sleep at night so they are less likely to feel sleepy during the day. It is FDA approved for this use. It's not clear if GHB supplements help.
Possibly Effective for
- Alcohol use disorder. Taking GHB by IV seems to reduce symptoms of alcohol withdrawal in people with alcohol use disorder. It's not clear if taking GHB by mouth helps. IV products can only be given by a healthcare provider.
Side Effects
GHB is unsafe and illegal for use as a dietary supplement. It can cause many serious side effects including hallucinations, confusion, memory loss, coma, and death. Long-term use can lead to addiction and withdrawal symptoms when it is stopped.
Special Precautions and Warnings
GHB is unsafe and illegal for use as a dietary supplement. It can cause many serious side effects including hallucinations, confusion, memory loss, coma, and death. Long-term use can lead to addiction and withdrawal symptoms when it is stopped.
Pregnancy and breast-feeding: GHB is unsafe. Don't use GHB if you are pregnant or breast-feeding. It's been linked with life-threatening side effects.
Slow heart rate (bradycardia): GHB should be avoided since it can slow the heart rate.
Seizure disorder (epilepsy): GHB might cause seizures in people with epilepsy. Avoid use.
Surgery: GHB can affect the central nervous system. It might cause too much sleepiness if it is used along with anesthesia and other medications used during and after surgery. Stop using GHB at least 2 weeks before a scheduled surgery. Talk to your doctor before stopping sodium oxybate (Xyrem).
A rare disorder called succinic semialdehyde dehydrogenase deficiency: People with this condition are at a greater risk for serious adverse reactions from GHB. Do not use GHB if you have this condition.
Interactions ?
Alcohol (Ethanol) interacts with GAMMA-HYDROXYBUTYRATE (GHB)
Alcohol can cause sleepiness and drowsiness. Taking GHB along with alcohol may greatly increase this effect. Do not take GHB if you have been drinking.
Sedative medications (CNS depressants) interacts with GAMMA-HYDROXYBUTYRATE (GHB)
GHB might cause sleepiness and slowed breathing. Some medications, called sedatives, can also cause sleepiness and slowed breathing. Taking GHB with sedative medications might cause breathing problems and/or too much sleepiness.
Divalproex sodium (Depakote) interacts with GAMMA-HYDROXYBUTYRATE (GHB)
Taking divalproex sodium at the same time as GHB might decrease how quickly the body gets rid of GHB. This could cause serious side effects.
Major Interaction
Do not take this combination
Amphetamines interacts with GAMMA-HYDROXYBUTYRATE (GHB)
Amphetamines are drugs that can speed up your nervous system. GHB can slow down your nervous system. Taking GHB along with amphetamines can lead to serious side effects.
Medications used to prevent seizures (Anticonvulsants) interacts with GAMMA-HYDROXYBUTYRATE (GHB)
GHB may increase the risk of seizures. Therefore, taking GHB may decrease the effects of medications used to prevent seizures. This might increase the risk of seizures.
Naloxone (Narcan) interacts with GAMMA-HYDROXYBUTYRATE (GHB)
GHB can affect the brain. Taking naloxone along with GHB might decrease the effects of GHB on the brain.
Ritonavir (Norvir) interacts with GAMMA-HYDROXYBUTYRATE (GHB)
Ritonavir and saquinavir are commonly used together for HIV/AIDS. Taking these medications with GHB might decrease how quickly the body gets rid of GHB. This could cause serious side effects.
Saquinavir (Fortovase, Invirase) interacts with GAMMA-HYDROXYBUTYRATE (GHB)
Saquinavir and ritonavir are commonly used together for HIV/AIDS. Taking both these medications with GHB might decrease how fast the body gets rid of GHB. This could cause serious side effects.
Topiramate (Topamax) interacts with GAMMA-HYDROXYBUTYRATE (GHB)
Taking topiramate plus GHB might decrease how quickly the body gets rid of GHB. This could cause serious side effects.
Moderate Interaction
Be cautious with this combination
Dosing
Abanades S, Farré M, Segura M, et al. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann N Y Acad Sci. 2006 Aug;1074:559-76. View abstract.
Abid M, Kietzerow J, Iwersen-Bergmann S, Schnitgerhans T, Andresen-Streichert H. Characteristics and dose-effect relationship of clinical gamma-hydroxybutyrate intoxication: A case series. J Forensic Sci 2022;67(1):416-427. View abstract.
Addolorato G, Cibin M, Caprista E, et al. Maintaining abstinence from alcohol with gamma hydroxybutyric acid. [Letter] Lancet 1998;351:38.
Anon. FDA alert on misuse of consumer products containing GHB, GBL and BD. Food and Drug Administration, Rockville, MD. June 15, 1999.
Anon. Important message for health professionals: Report serious adverse events associated with dietary supplements containing GBL, GHB or BD. Food and Drug Administration, Rockville, MD. August 25, 1999. Available at: https://vm.cfsan.fda.gov/~dms/mwgblghb.html
Anon. Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate. JAMA 1991;265:447-8.
Aronsen AC, Brekke M, Vallersnes OM. Acute poisoning with gamma-hydroxybutyrate. Tidsskr Nor Laegeforen 2020;140(10). View abstract.
Bosch OG, Eisenegger C, Gertsch J, et al. Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone. Psychoneuroendocrinology. 2015 Dec;62:1-10. View abstract.
Boscolo-Berto R, Viel G, Montagnese S, Raduazzo DI, Ferrara SD, Dauvilliers Y. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2012 Oct;16(5):431-43. View abstract.
Brennan R, Van Hout MC. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups. J Psychoactive Drugs. 2014 Jul-Aug;46(3):243-51. View abstract.
Broughton R, Mamelak M. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci 1979;6:1-6. View abstract.
Cash CD. Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent (abstract). Neurosci Biobehav Rev 1994;18:291-304. View abstract.
Cash CD. What is the role of the gamma-hydroxybutyrate receptor? Med Hypotheses 1996;47:455-9. View abstract.
Dornbierer DA, Kometer M, Von Rotz R, et al. Effects of gamma-hydroxybutyrate on neurophysiological correlates of performance and conflict monitoring. Eur Neuropsychopharmacol 2019;29(4):539-48. doi: 10.1016/j.euroneuro.2019.02.004. View abstract.
Drogies T, Willenberg A, Ramshorn-Zimmer A, et al.. Detection of gamma hydroxybutyrate in emergency department: Nice to have or a valuable diagnostic tool? Hum Exp Toxicol. 2016 Jul;35(7):785-92. View abstract.
Dyer J, Roth B, Hyma B. Gamma-Hydroxybutyrate withdrawal syndrome. Ann Emerg Med 2001;37:147-53.. View abstract.
Dyer JE. Gamma-Hydroxybutyrate: a health-food product producing coma and seizure-like activity (abstract). Am J Emerg Med 1991;9:321-4. View abstract.
FDA Talk Paper. FDA Warns About GBL-Related Products. 1999. Available at: vm.cfsan.fda.gov/~lrd/tpgbl2.html
FDA Talk Paper. FDA Approves Xyrem for Cataplexy Attacks in Patients with Narcolepsy. Issued July 17, 2002. Availbale at: https://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01157.html
Feigenbaum JJ, Howard SG. Gamma hydroxybutyrate is not a GABA agonist (abstract). Prog Neurobiol 1996;50:1-7. View abstract.
Gallimberti L, Canton G, Gentile N, et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 1989;2:787-9. View abstract.
Gallimberti L, Cibin M, Pagnin P, et al. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology 1993;9:77-81. View abstract.
Gallimberti L, Ferri M, Ferrara SD, et al. Gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol Clin Exp Res 1992;16:673-6. View abstract.
Gallimberti L, Schifano F, Forza G, et al. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur Arch Psychiatry Clin Neurosci 1994;244:113-4. View abstract.
Galloway GP, Frederick SL, Staggers FE Jr, et al. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997;92:89-96. View abstract.
Gerra G, Caccavari R, Fontanesi B, et al. Naloxone and metergoline effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol 1995;10:245-50. View abstract.
Guiraud J, Addolorato G, Aubin HJ, et al. Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study. Eur Neuropsychopharmacol 2021;52:18-30. View abstract.
Harrington RD, Woodward JA, Hooton TM, et al. Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate. Arch Intern Med 1999;159:2221-4. View abstract.
Hillory J. Farias and Samantha Reid date-rape drug prohibition act of 2000. 106th Congress of the United States of America. HR 2130.
Hoes MJ, Vree TB, Guelen PJ. Gamma-hydroxybutyric acid as hypnotic. Clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man. Encephale 1980;6:93-9. View abstract.
Ingels M, Rangan C, Bellezzo J, Clark R. Coma and respiratory depression following the ingestion of GHB and its precursors: Three cases. J Emerg Med 2000;19:47-50.. View abstract.
Kalra MA, Hart LL. Gammahydroxybutyrate in narcolepsy. Ann Pharmacother 1992;26:647-8.
Kuiper MA, Peikert N, Boerma EC. Gamma-hydroxybutyrate withdrawal syndrome: a case report. Cases J. 2009 Mar 25;2:6530. View abstract.
Lee S, Boyce SL, Southwell J. Case of gamma-hydroxybutyrate poisoning in an infant. J Paediatr Child Health 2022;58(5):909-910. View abstract.
Leone MA, Vigna-Taglianti F, Avanzi G, Brambilla R, Faggiano F. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006266. View abstract.
Liakoni E, Dempsey DA, Meyers M, et al. Effect of ?-hydroxybutyrate (GHB) on driving as measured by a driving simulator. Psychopharmacology (Berl) 2018;235(11):3223-32. doi: 10.1007/s00213-018-5025-2. View abstract.
Maitre M. The gamma-hydroxybutyrate signaling system in brain: organization and functional implications (abstract). Prog Neurobiol 1997;51:337-61. View abstract.
Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism (abstract). Neurosci Biobehav Rev 1989;13:187-98. View abstract.
Mason P, Kerns II W. Gamma Hydroxybutyric Acid (GHB) Intoxication. Acad Emerg Med 2002;9:730-39.. View abstract.
Nava F, Premi S, Manzato E, Campagnola W, Lucchini A, Gessa GL. Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam. Am J Drug Alcohol Abuse. 2007;33(3):379-92. View abstract.
Németh Z, Kun B, Demetrovics Z. The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review. J Psychopharmacol. 2010 Sep;24(9):1281-7. View abstract.
Nimmerrichter AA, Walter H, Gutierrez-Lobos KE, Lesch OM. Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol Alcohol. 2002 Jan-Feb;37(1):67-73. View abstract.
Oliveto A, Gentry WB, Pruzinsky R, et al. Behavioral effects of gamma-hydroxybutyrate in humans. Behav Pharmacol. 2010 Jul;21(4):332-42. View abstract.
Otto A. Acquaintance rape drug may one day help instead of hurt (news). Pharmacy Today. American Pharmaceutical Association, Washington, DC. April 2000:17.
Price G. In-patient detoxification after GHB dependence. Br J Psychiatry 2000;177:181.
Product information for Xyrem. Jazz Pharmaceuticals, Inc. Palo Alto, CA. March 2022.
Raposo Pereira F, McMaster MTB, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA. Adverse effects of GHB-induced coma on long-term memory and related brain function. Drug Alcohol Depend 2018;190:29-36. doi: 10.1016/j.drugalcdep.2018.05.019. View abstract.
Raposo Pereira F, McMaster MTB, Schellekens A, et al. Effects of Recreational GHB Use and Multiple GHB-Induced Comas on Brain Structure and Impulsivity. Front Psychiatry 2020;11:166. View abstract.
Rodriguez-Cruz V, Ren T, Morris ME. Drug-drug interaction between diclofenac and gamma-hydroxybutyric acid. Biopharm Drug Dispos 2021;42(8):351-358. View abstract.
Scharf MB, Brown D, Woods M, et al. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 1985;46:222-5. View abstract.
Scharf MB, Hauck M, Stover R, et al. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report. J Rheumatol 1998;25:1986-90. View abstract.
Scrima L, Hartman PG, Johnson FH Jr, et al. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep 1990;13:479-90. View abstract.
Scrima L, Hartman PG, Johnson FH Jr, Hiller FC. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures. Biol Psychiatry 1989;26:331-43. View abstract.
Smith KM. Drugs used in acquaintance rape. J Am Pharm Assoc 1999;39:519-25. View abstract.
Stomberg MW, Knudsen K, Stomberg H, Skärsäter I. Symptoms and signs in interpreting gamma-hydroxybutyrate (GHB) intoxication - an explorative study. Scand J Trauma Resusc Emerg Med. 2014 Apr 23;22:27. View abstract.
Thai D, Dyer JE, Benowitz NL, Haller CA. Gamma-hydroxybutyrate and ethanol effects and interactions in humans. J Clin Psychopharmacol. 2006 Oct;26(5):524-9. View abstract.
Thai D, Dyer JE, Jacob P, Haller CA. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers. Clin Pharmacol Ther. 2007 Feb;81(2):178-84. View abstract.
Timby N, Eriksson A. Gamma-Hydroxybutyrate-Associated Deaths. Am J Med 2000;108:518.
Tunnicliff G. Significance of gamma-hydroxybutyric acid in the brain. Gen Pharmacol 1992;23:1027-34. View abstract.
Tunnicliff, G. Sites of action of gamma-hydroxybutyrate (GHB)-a neuroactive drug with abuse potential. J Toxicol Clin Toxicol 1997;35:581-90. View abstract.
Van Cauter E, Plat L, Scharf MB, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men (abstract). J Clin Invest 1997;100:745-53. View abstract.
van Noorden MS, Kamal RM, Dijkstra BA, Mauritz R, de Jong CA. A case series of pharmaceutical gamma-hydroxybutyrate in 3 patients with severe benzodiazepine-resistant gamma-hydroxybutyrate withdrawal in the hospital. Psychosomatics. 2015 Jul-Aug;56(4):404-9. View abstract.
Weiss T, Müller D, Marti I, Happold C, Russmann S. Gamma-hydroxybutyrate (GHB) and topiramate--clinically relevant drug interaction suggested by a case of coma and increased plasma GHB concentration. Eur J Clin Pharmacol. 2013 May;69(5):1193-4.View abstract.
Wolf CJH, Beurmanjer H, Dijkstra BAG, et al. Characterization of the GHB Withdrawal Syndrome. J Clin Med 2021;10(11):2333. View abstract.
Xu XM, Wei YD, Liu Y, Li ZX. Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis. Sleep Med 2019;64:62-70. doi: 10.1016/j.sleep.2019.06.017. View abstract.
Select a condition to view a list of vitamins
You Might Also Like
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2020.